Benzinga's options scanner just detected over 10 options trades for ResMed RMD summing a total amount of $532,171.
At the same time, our algo caught 3 for a total amount of 179,581.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $175.0 to $200.0 for ResMed over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for ResMed's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of ResMed's whale activity within a strike price range from $175.0 to $200.0 in the last 30 days.
ResMed Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | PUT | SWEEP | BULLISH | 05/17/24 | $9.0 | $8.3 | $8.7 | $185.00 | $96.5K | 586 | 19 |
| RMD | CALL | TRADE | BULLISH | 05/17/24 | $11.8 | $10.8 | $11.8 | $175.00 | $70.8K | 640 | 60 |
| RMD | CALL | SWEEP | BULLISH | 05/17/24 | $3.3 | $2.95 | $3.2 | $195.00 | $64.0K | 295 | 200 |
| RMD | CALL | TRADE | BULLISH | 05/17/24 | $12.0 | $11.4 | $12.0 | $175.00 | $48.0K | 640 | 120 |
| RMD | CALL | SWEEP | BULLISH | 05/17/24 | $13.0 | $12.6 | $12.8 | $175.00 | $44.8K | 640 | 200 |
About ResMed
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Where Is ResMed Standing Right Now?
- With a trading volume of 153,131, the price of RMD is up by 1.47%, reaching $183.0.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 2 days from now.
Expert Opinions on ResMed
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $219.5.
- An analyst from Mizuho persists with their Buy rating on ResMed, maintaining a target price of $215.
- Consistent in their evaluation, an analyst from Needham keeps a Buy rating on ResMed with a target price of $224.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ResMed options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
